Open AccessDetecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel
Author(s) -
Cornelius J. Clancy,
Peter G. Pappas,
José A. Vázquez,
Marc A. Judson,
Dimitrios P. Kontoyiannis,
George R. Thompson,
Kevin W. Garey,
Annette C. Reboli,
Richard N. Greenberg,
Senu Apewokin,
G. Marshall Lyon,
Luis OstroskyZeichner,
Alan H.B. Wu,
Ellis Tobin,
M. Hong Nguyen,
Angela M. Caliendo
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1095
Subject(s) - medicine , multicenter study , intensive care medicine , randomized controlled trial
Blood cultures are approximately 50% sensitive for diagnosing invasive candidiasis. The T2Candida nanodiagnostic panel uses T2 magnetic resonance and a dedicated instrument to detect Candida directly within whole blood samples.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom